Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Lung Cancer

  Free Subscription


27.07.2020

1 Am J Clin Oncol
1 Am J Ind Med
3 Ann Surg Oncol
1 Ann Thorac Surg
2 Arch Pathol Lab Med
1 BMC Cancer
3 Br J Cancer
2 Cancer
1 Cancer Epidemiol Biomarkers Prev
1 Cancer Res
2 Cancer Sci
3 Clin Lung Cancer
1 J Cancer Res Clin Oncol
5 J Thorac Cardiovasc Surg
6 Lung Cancer
1 PLoS Comput Biol
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Clin Oncol

  1. RAPP JL, Tuminello S, Alpert N, Flores RM, et al
    Disparities in Surgical Recommendation for Stage I Non-Small Cell Lung Cancer.
    Am J Clin Oncol. 2020 Jul 21. doi: 10.1097/COC.0000000000000740.
    PubMed         Abstract available


    Am J Ind Med

  2. GIBB H, Wang J, O'Leary K, Chen C, et al
    The effect of age on the relative risk of lung cancer mortality in a cohort of chromium production workers.
    Am J Ind Med. 2020 Jul 20. doi: 10.1002/ajim.23152.
    PubMed         Abstract available


    Ann Surg Oncol

  3. MASCALCHI M
    Lung Cancer Associated with Cystic Airspaces in the Screening Perspective.
    Ann Surg Oncol. 2020 Jul 22. pii: 10.1245/s10434-020-08929.
    PubMed        

  4. LIU C, Wei S, Liu L
    ASO Author Reflections: Individualized Mediastinal Lymph Node Dissection for Lung Cancer: Do Not Neglect Station 3A Lymph Node.
    Ann Surg Oncol. 2020 Jul 20. pii: 10.1245/s10434-020-08876.
    PubMed        

  5. TAKAMORI S, Shimokawa M, Matsubara T, Haratake N, et al
    Prognostic Impact of Smoking Period in Patients with Surgically Resected Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2020 Jul 16. pii: 10.1245/s10434-020-08851.
    PubMed         Abstract available


    Ann Thorac Surg

  6. YU PSY, Chu CM, Lau RWH, Ng CSH, et al
    Hybrid Theatre Facilitates Lung-Preserving Multimodal Treatment for Multiple Pulmonary Metastases.
    Ann Thorac Surg. 2020 Jul 16. pii: S0003-4975(20)31144.
    PubMed         Abstract available


    Arch Pathol Lab Med

  7. REKHTMAN N
    "Napoleon Hat" Sign: A Distinctive Cytologic Clue to Reactive Pneumocytes.
    Arch Pathol Lab Med. 2020;144:443-445.
    PubMed         Abstract available

  8. LE STANG N, Burke L, Blaizot G, Gibbs AR, et al
    Differential Diagnosis of Epithelioid Malignant Mesothelioma With Lung and Breast Pleural Metastasis: A Systematic Review Compared With a Standardized Panel of Antibodies-A New Proposal That May Influence Pathologic Practice.
    Arch Pathol Lab Med. 2020;144:446-456.
    PubMed         Abstract available


    BMC Cancer

  9. JIA B, Zheng Q, Wang J, Sun H, et al
    A nomogram model to predict death rate among non-small cell lung cancer (NSCLC) patients with surgery in surveillance, epidemiology, and end results (SEER) database.
    BMC Cancer. 2020;20:666.
    PubMed         Abstract available


    Br J Cancer

  10. LUANPITPONG S, Rodboon N, Samart P, Vinayanuwattikun C, et al
    A novel TRPM7/O-GlcNAc axis mediates tumour cell motility and metastasis by stabilising c-Myc and caveolin-1 in lung carcinoma.
    Br J Cancer. 2020 Jul 20. pii: 10.1038/s41416-020-0991.
    PubMed         Abstract available

  11. URSO L, Cavallari I, Sharova E, Ciccarese F, et al
    Metabolic rewiring and redox alterations in malignant pleural mesothelioma.
    Br J Cancer. 2020;122:52-61.
    PubMed         Abstract available

  12. GOMES F, Wong M, Battisti NML, Kordbacheh T, et al
    Immunotherapy in older patients with non-small cell lung cancer: Young International Society of Geriatric Oncology position paper.
    Br J Cancer. 2020 Jul 22. pii: 10.1038/s41416-020-0986.
    PubMed         Abstract available


    Cancer

  13. DURM GA, Jabbour SK, Althouse SK, Liu Z, et al
    A phase 2 trial of consolidation pembrolizumab following concurrent chemoradiation for patients with unresectable stage III non-small cell lung cancer: Hoosier cancer research network LUN 14-179.
    Cancer. 2020 Jul 22. doi: 10.1002/cncr.33083.
    PubMed         Abstract available

  14. STEINDL A, Yadavalli S, Gruber KA, Seiwald M, et al
    Neurological symptom burden impacts survival prognosis in patients with newly diagnosed non-small cell lung cancer brain metastases.
    Cancer. 2020 Jul 17. doi: 10.1002/cncr.33085.
    PubMed         Abstract available


    Cancer Epidemiol Biomarkers Prev

  15. BRHANE Y, Yang P, Christiani DC, Liu G, et al
    Genetic determinants of lung cancer prognosis in never smokers: A pooled analysis in the International Lung Cancer Consortium.
    Cancer Epidemiol Biomarkers Prev. 2020 Jul 22. pii: 1055-9965.EPI-20-0248.
    PubMed         Abstract available


    Cancer Res

  16. ZHENG X, Weigert A, Reu S, Guenther S, et al
    Spatial Density and Distribution of Tumor-Associated Macrophages Predict Survival in Non-Small-Cell Lung Carcinoma.
    Cancer Res. 2020 Jul 22. pii: 0008-5472.CAN-20-0069.
    PubMed         Abstract available


    Cancer Sci

  17. SETO T, Hayashi H, Satouchi M, Goto Y, et al
    Lorlatinib in previously-treated ALK-rearranged non-small cell lung cancer: Japanese subgroup analysis of a global study.
    Cancer Sci. 2020 Jul 18. doi: 10.1111/cas.14576.
    PubMed         Abstract available

  18. OHGINO K, Terai H, Yasuda H, Nukaga S, et al
    Intracellular levels of reactive oxygen species correlate with ABT-263 sensitivity in non-small cell lung cancer cells.
    Cancer Sci. 2020 Jul 20. doi: 10.1111/cas.14569.
    PubMed         Abstract available


    Clin Lung Cancer

  19. ZHAO Y, Zhai L, Deng L, Halmos B, et al
    Efficacy of Osimertinib in Afatinib-resistant Lung Cancer Harboring Uncommon EGFR Mutations: Case Report and Literature Review.
    Clin Lung Cancer. 2020 Jun 19. pii: S1525-7304(20)30211.
    PubMed        

  20. MIERAS A, Pasman HRW, Klop HT, Onwuteaka-Philipsen BD, et al
    What Goals Do Patients and Oncologists Have When Starting Medical Treatment for Metastatic Lung Cancer?
    Clin Lung Cancer. 2020 Jun 21. pii: S1525-7304(20)30208.
    PubMed         Abstract available

  21. MULLER DA, Dutta SW, Aliotta E, Sanders JC, et al
    Clinical Outcomes and Predictors of Lung Toxicity After Multiple Courses of Lung Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer.
    Clin Lung Cancer. 2020 Jun 12. pii: S1525-7304(20)30188.
    PubMed         Abstract available


    J Cancer Res Clin Oncol

  22. CHEN SS, Li K, Wu J, Peng ZY, et al
    Stem signatures associated antibodies yield early diagnosis and precise prognosis predication of patients with non-small cell lung cancer.
    J Cancer Res Clin Oncol. 2020 Jul 20. pii: 10.1007/s00432-020-03325.
    PubMed         Abstract available


    J Thorac Cardiovasc Surg

  23. LAZAR JF
    Commentary: How to "spot" a leopard: It's in the genes.
    J Thorac Cardiovasc Surg. 2020;160:e82-e83.
    PubMed        

  24. LIU C, Tian D, Pu Q
    Do not go too far when choosing intentional segmentectomy for small-sized lung cancers.
    J Thorac Cardiovasc Surg. 2020;160:e85-e86.
    PubMed        

  25. RAZI SS, Nguyen D, Villamizar N
    Reply from authors: Positive nodes after segmentectomy: Take a deep breath and give adjuvant treatment.
    J Thorac Cardiovasc Surg. 2020;160:e86-e87.
    PubMed        

  26. JEFFREY YANG CF, Berry MF
    Reply: The importance of appropriate selection for segmentectomy.
    J Thorac Cardiovasc Surg. 2020;160:e87.
    PubMed        

  27. PATEL S, Kim AW
    Commentary: Standing on similar, but different, shoulders.
    J Thorac Cardiovasc Surg. 2020;160:e81-e82.
    PubMed        


    Lung Cancer

  28. WANG Q, Li X, Ren S, Su C, et al
    HOTAIR induces EGFR-TKIs resistance in non-small cell lung cancer through epithelial-mesenchymal transition.
    Lung Cancer. 2020;147:99-105.
    PubMed         Abstract available

  29. ZHENG J, Cao H, Li Y, Rao C, et al
    Effectiveness and prognostic factors of first-line crizotinib treatment in patients with ROS1-rearranged non-small cell lung cancer: A multicenter retrospective study.
    Lung Cancer. 2020;147:130-136.
    PubMed         Abstract available

  30. VARLOTTO JM, Voland R, DeCamp MM, Rava P, et al
    The rates of second lung cancers and the survival of surgically-resected second primary lung cancers in patients undergoing resection of an initial primary lung cancer.
    Lung Cancer. 2020;147:115-122.
    PubMed         Abstract available

  31. REMON J, Nadal E, Domine M, Ruffinelli J, et al
    Malignant pleural mesothelioma: Treatment patterns and outcomes from the Spanish Lung Cancer Group.
    Lung Cancer. 2020;147:83-90.
    PubMed         Abstract available

  32. SVEDBERG A, Bjorn N, Sigurgeirsson B, Pradhananga S, et al
    Genetic association of gemcitabine/carboplatin-induced leukopenia and neutropenia in non-small cell lung cancer patients using whole-exome sequencing.
    Lung Cancer. 2020;147:106-114.
    PubMed         Abstract available

  33. BEN DORI S, Aizic A, Sabo E, Hershkovitz D, et al
    Spatial heterogeneity of PD-L1 expression and the risk for misclassification of PD-L1 immunohistochemistry in non-small cell lung cancer.
    Lung Cancer. 2020;147:91-98.
    PubMed         Abstract available


    PLoS Comput Biol

  34. LUO C, Fa B, Yan Y, Wang Y, et al
    High-dimensional mediation analysis in survival models.
    PLoS Comput Biol. 2020;16:e1007768.
    PubMed         Abstract available


    PLoS One

  35. WANG C, Zhang J, Zhou S, Yu L, et al
    Tentative identification of gefitinib metabolites in non-small-cell lung cancer patient plasma using ultra-performance liquid chromatography coupled with triple quadrupole time-of-flight mass spectrometry.
    PLoS One. 2020;15:e0236523.
    PubMed         Abstract available

  36. KIM N, Kim JS, Geol Lee C
    Predictive value of interim 18F-FDG-PET in patients with non-small cell lung cancer treated with definitive radiation therapy.
    PLoS One. 2020;15:e0236350.
    PubMed         Abstract available

  37. GASILINA A, Premnauth G, Gurjar P, Biesiada J, et al
    IODVA1, a guanidinobenzimidazole derivative, targets Rac activity and Ras-driven cancer models.
    PLoS One. 2020;15:e0229801.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: